Krishnan Nandabalan
Oprichter bij BioXcel Corp.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Vimal Mehta | M | 63 |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation.
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 19 jaar |
| Sandeep Laumas | M | 56 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation.
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 11 jaar |
| Robert Sarrazin | M | - |
Autism Impact Fund
 Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | 4 jaar |
| Kerrie L. Brady | F | 62 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
| Patricia Spera | M | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
| Jason Fenton | M | 48 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 jaar |
| June Bray | F | 70 | 3 jaar | |
| Frank Yocca | M | 68 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | 9 jaar |
| Jonathan Zalevsky | M | 49 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
| Michael Miller | M | 67 | 2 jaar | |
| Michal Votruba | M | 58 | 5 jaar | |
| Javier Rodriguez | M | 52 | 3 jaar | |
| Demetrios Kydonieus | M | 54 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
| Christopher Male | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | 4 jaar |
| Richard Steinhart | M | 66 | 7 jaar | |
| Cuong Viet Do | M | 58 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Kelly Patterson | F | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | 3 jaar |
| Richard S. Judson | M | 65 |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | 25 jaar |
| Salvatore Alesci | M | 50 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 jaar |
| Michael Snyder | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Pramila Srinivasan | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Eric Rowinsky | M | 67 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | 7 jaar |
| Alison Singer | F | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Amanda Lukof | F | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Brian O’Callaghan | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | 4 jaar |
| David Amaral | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Richard Frye | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Ian Marks | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Shunichiro Okada | M | 66 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 jaar |
| Aman Kant | M | 40 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
| Sheryl Bauer | F | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 jaar |
| Matthew Wiley | M | 52 | 2 jaar | |
| Bob Nelsen | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Ashok Srinivasan | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | 3 jaar |
| Raymond Gellein | M | 76 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Simon Cohen | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Michael Aiello | M | 44 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
| Laurence Derose | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Erik Kopp | M | - | 3 jaar | |
| Arun Gupta | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Elizabeth Horn | F | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Vincent O'Neill | M | 55 | 7 jaar | |
| Daniel Tarman | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Sarah Hassan | F | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Michael Smart | M | 64 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Johan Henrik Andresen | M | 63 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | 3 jaar |
| Thomas Insel | M | 72 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Jennifer Frist | F | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Brian Jacobs | M | 63 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Sean O’Sullivan | M | - |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Dara Khosrowshahi | M | 54 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | - |
| Anita Ganjoo | M | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Chids Mahadevan | M | 53 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | 4 jaar |
| Robin Smith | M | 59 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | 2 jaar |
| Joseph Klein | M | 62 |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | 2 jaar |
| Christopher Wright | M | 67 |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | - |
| Jeffrey Otto | M | - |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | 5 jaar |
| Carol R. Reed | M | 71 |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | 2 jaar |
| Chad Messer | M | - |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | 3 jaar |
| William Kane | M | 62 | 1 jaar | |
| Jennifer Barretta | F | - |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | 5 jaar |
| Cedric Burg | M | - | - | |
| David Hanley | M | 54 | 3 jaar | |
| Reina Benabou | M | 60 | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 64 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Krishnan Nandabalan
- Persoonlijk netwerk
